Wuppertal, Germany, January 19, 2011 / b3c newswire /– AiCuris today announced that Dr. Marie-Paule Richard has assumed the responsibility of Chief Medical Officer at
After six years at Bristol-Myers Squibb as a medical-marketing Manager, Dr Richard joined Aventis Pharma as European Clinical Project Manager in a French-Japanese joint-venture, then as Director in the global anti-infectives corporate clinical department. In 2000, she joined GlaxoSmithKline in the
Dr. Richard is an M.D., she received her diploma in clinical immunology, pharmacology/ pharmacokinetics, and an MBA from CEDEP-INSEAD.
"We are very pleased to see Dr. Richard join the team at AiCuris as CMO. She has a profound background in infectious diseases and a great development and management expertise", comments AiCuris CEO, Prof. Helga Rübsamen-Schaeff.
"I am extremely happy to join the experienced and highly qualified Development team at AiCuris. The R&D portfolio is very promising and I am thrilled with this opportunity to develop this portfolio further at AiCuris and to bring my competences to the Management Team", adds Dr. Marie-Paule Richard.
About AiCuris - ww.aicuris.com
AiCuris GmbH & Co KG (the name is derived from: anti infective cures) is a privately held company located in
Link to the high resolution picture: http://www.aicuris.com/images/dsc_0168.jpg
AiCuris GmbH & Co. KG
Friedrich-Ebert-Str. 475/Building 302
Phone +49 202 317 63 1176
Fax +49 202 317 63 1177